Tocilizumab-associated GI perforation

Appears 2×

Teaching point

Tocilizumab (IL-6 inhibitor) is associated with lower GI (sigmoid/diverticular) perforation; in an RA patient on tocilizumab with sigmoid perforation, the drug is the most likely cause.

🔒 This is premium content

Unlock the teaching point, every stem variant and the answer keys for all specialties with a subscription.